The Association Between Intra-abdominal Pressure and Diuretic Response in Heart Failure.

IF 3.8 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Heart Failure Reports Pub Date : 2023-10-01 Epub Date: 2023-07-29 DOI:10.1007/s11897-023-00617-x

S Crespo-Aznarez, A Campos-Sáenz de Santamaría, M Sánchez-Marteles, V Garcés-Horna, C Josa-Laorden, I Giménez-López, J I Pérez-Calvo, J Rubio-Gracia

{"title":"The Association Between Intra-abdominal Pressure and Diuretic Response in Heart Failure.","authors":"S Crespo-Aznarez, A Campos-Sáenz de Santamaría, M Sánchez-Marteles, V Garcés-Horna, C Josa-Laorden, I Giménez-López, J I Pérez-Calvo, J Rubio-Gracia","doi":"10.1007/s11897-023-00617-x","DOIUrl":null,"url":null,"abstract":"Purpose of the review: An efficient diuretic response is vital during cardiac decompensation in heart failure (HF) patients. The increase in intra-abdominal pressure (IAP) could be one of the keys for understanding cardiorenal syndrome and guiding diuretic treatment during hospitalization. In this review, we analyze the relationship between IAP and diuretic response in HF patients.Recent findings: Increased IAP is associated with worsening renal function (WRF) in patients with advanced HF. Furthermore, the persistence of a rise in IAP after the first 72 h of intravenous diuretic treatment has been correlated with a worse diuretic response, a higher degree of congestion, and an impaired prognosis. The rise in IAP in HF patients has been associated with impaired renal function and a lower diuretic response. Nonetheless, more studies are needed to elucidate the actual role of IAP in congestive nephropathy and whether it may help guide diuretic therapy during acute decompensations.","PeriodicalId":10830,"journal":{"name":"Current Heart Failure Reports","volume":" ","pages":"390-400"},"PeriodicalIF":3.8000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Heart Failure Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11897-023-00617-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of the review: An efficient diuretic response is vital during cardiac decompensation in heart failure (HF) patients. The increase in intra-abdominal pressure (IAP) could be one of the keys for understanding cardiorenal syndrome and guiding diuretic treatment during hospitalization. In this review, we analyze the relationship between IAP and diuretic response in HF patients.

Recent findings: Increased IAP is associated with worsening renal function (WRF) in patients with advanced HF. Furthermore, the persistence of a rise in IAP after the first 72 h of intravenous diuretic treatment has been correlated with a worse diuretic response, a higher degree of congestion, and an impaired prognosis. The rise in IAP in HF patients has been associated with impaired renal function and a lower diuretic response. Nonetheless, more studies are needed to elucidate the actual role of IAP in congestive nephropathy and whether it may help guide diuretic therapy during acute decompensations.

查看原文本刊更多论文

心力衰竭患者腹腔内压力与利尿反应的关系。

综述的目的：在心力衰竭（HF）患者的心脏失代偿期，有效的利尿反应至关重要。腹腔内压（IAP）的升高可能是了解心肾综合征和指导住院期间利尿剂治疗的关键之一。在这篇综述中，我们分析了HF患者IAP与利尿反应之间的关系。最近的研究结果：晚期HF患者的IAP升高与肾功能（WRF）恶化有关。此外，静脉注射利尿剂治疗前72小时IAP持续升高与利尿剂反应更差、充血程度更高和预后受损有关。HF患者IAP的升高与肾功能受损和利尿反应降低有关。尽管如此，还需要更多的研究来阐明IAP在充血性肾病中的实际作用，以及它是否有助于指导急性失代偿期的利尿治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Heart Failure Reports Medicine-Emergency Medicine

CiteScore

5.30

自引率

0.00%

发文量

期刊介绍： This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of heart failure. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as investigative, pharmacologic, and nonpharmacologic therapies, pathophysiology, and prevention. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.